Genoskin is a pioneering contract research organization that leverages ethically sourced human skin to accelerate the development of biotherapies, vaccines, medical devices, and cosmetics. By integrating advanced technologies like transcriptomics, spatial biology, and bioinformatics with our ex vivo human skin models, we offer a robust platform for predicting compound efficacy and safety before human trials. Our models provide unparalleled insights into substance interactions, absorption, irritation, and overall skin response, reducing time-to-market and minimizing development risks. Committed to ethical research, we replace animal testing with human-relevant data, driving innovation in the biomedical, cosmetics, and skincare products industry.
Industry
Biotechnology Research, Biotechnology research and development, Research and testing, IT, Internet, R&D
HQ Location
4 Technology Way
Salem, Massachusetts 01970, US
Keywords
Skin explantVaccine developmentCosmetics testingMast cellsContract research organization (CRO)Medical devices testingToxicity testingInjection site reactionsLive human tissuePreclinical drug development